This suggest that sclerostin may mitigate the susceptibility to atherosclerosis by decreasing atherosclerotic plaque related to improved cardiovascular risk factors such as LDL-c, calcium, and diastolic blood pressure. Here, SOST is linked to atherosclerosis.